Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Concentrix stock downgraded on weak demand outlook

EditorAhmed Abdulazez Abdulkadir
Published 03/28/2024, 06:54 PM
Updated 03/28/2024, 06:54 PM

On Thursday, BofA Securities revised its rating for Concentrix Corp. (NASDAQ:CNXC), shifting from Neutral to Underperform. The decision came after the company's first-quarter revenues aligned with the higher end of their guidance, but the operating margin (OM) fell slightly below the midpoint and BofA Securities' estimates.

Furthermore, the second-quarter revenue and earnings per share (EPS) are anticipated to be lower than both the firm's and the broader market's expectations. The operating margin guidance for the quarter also shows a 20 basis point decline from previous estimates.

Despite maintaining its full-year 2024 guidance for revenue, operating margin, and EPS, including a projected increase in stock buybacks, BofA Securities points out that this implies a more significant effort will be needed in the latter half of the year to meet the operating margin targets. This is a steeper climb compared to their earlier estimates. The anticipated benefits from the increased buybacks are likely to be neutralized by a rise in interest expenses, due to delays in anticipated rate cuts that were factored into previous guidance.

BofA Securities has adjusted its full-year 2024 revenue and EPS estimates for Concentrix to the lower end of the company's guidance range, a decrease from the prior midpoint. The analyst cited the current weak demand environment and the absence of significant near-term catalysts as reasons for the downgrade.

Additionally, the long-term implications of artificial intelligence on the company's operations remain unclear, further contributing to the cautious outlook on the stock.

The report reflects concerns about the company's short-term performance prospects and potential challenges in achieving its full-year targets. The downgrade signals a cautious stance from BofA Securities in light of the factors affecting Concentrix's business trajectory.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

InvestingPro Insights

In light of BofA Securities' recent downgrade of Concentrix Corp. (NASDAQ:CNXC), it's important to consider some key metrics and insights from InvestingPro. The company has demonstrated a commitment to shareholder value with a dividend that has been raised for three consecutive years. Additionally, InvestingPro data indicates that Concentrix has a market capitalization of $4.11 billion and a relatively attractive P/E ratio of 13.21, which adjusts to an even more appealing 12.34 when considering the last twelve months as of Q1 2024. This suggests that the company is being valued reasonably by the market in terms of earnings.

Moreover, Concentrix has shown robust revenue growth of 22.67% over the last twelve months, with a particularly strong quarterly increase of 46.83% in Q1 2024. This growth is coupled with a solid gross profit margin of 36.2%. Despite the short-term concerns raised by BofA Securities, analysts predict that Concentrix will be profitable this year, with net income expected to grow. Furthermore, the company's liquid assets exceed its short-term obligations, indicating a healthy financial position.

For investors seeking a more in-depth analysis, there are additional InvestingPro Tips available, including insights into earnings revisions and sales growth expectations. To explore these further and take advantage of a special offer, use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at InvestingPro. There are a total of 8 additional InvestingPro Tips that could provide valuable guidance in assessing Concentrix's future performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.